tiprankstipranks
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market
CBIO
Crescent Biopharma
RESEARCH TOOLSreports
Want to see CBIO full AI Analyst Report?

Crescent Biopharma (CBIO) Income Statement

1,026 Followers

Crescent Biopharma Income Statement

Last quarter (Q1 2026), Crescent Biopharma's total revenue was $1.04M, an increase of Infinity% from the same quarter last year. In Q1, Crescent Biopharma's net income was $-23.28M. See Crescent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 10.84M$ 0.00$ 10.00K$ 75.00K$ 1.16M
Gross Profit
$ 10.84M$ 0.00$ 10.00K$ 75.00K$ 1.16M
Operating Expenses
$ 163.48M$ 49.90M$ 39.29M$ 47.48M$ 64.61M
Depreciation and Amortization
$ 84.00K$ 35.17K$ 153.30K$ 207.15K$ 264.60K
EBITDA
$ -149.67M$ -44.17M$ -39.12M$ -47.20M$ -63.18M
Operating Income
$ -152.63M$ -49.90M$ -39.28M$ -47.40M$ -63.45M
Other Income/Expenses
$ 690.00K$ 1.37M$ 2.38M$ 714.96K$ 19.77K
Pretax Income
$ -151.94M$ -48.52M$ -36.90M$ -46.69M$ -63.43M
Net Income
$ -153.94M$ -48.52M$ -36.90M$ -46.69M$ -63.43M
Per Share Metrics
Basic EPS
$ -14.78$ -1.40$ -0.58$ -0.89$ -1.23
Diluted EPS
$ -14.78$ -1.40$ -0.58$ -0.89$ -1.23
Weighted Average Shares Outstanding
 10.41M 19.50M 63.34M 52.53M 51.45M
Weighted Average Shares Outstanding (Diluted)
 10.41M 19.50M 63.34M 52.53M 51.45M
Currency in USD

Crescent Biopharma Earnings and Revenue History